Rheumatoid Arthritis

In this slideshow, we highlight the best of RA mobile apps that are designed to track disease activity. The list, a total of 19 apps, is based on a scientific review that was published in February.

Patients sometimes insist on non-traditional therapies after a rheumatoid arthritis diagnosis. Their concerns shouldn't be ignored and instead, patients should be counseled on therapeutic options.

Rheumatoid arthritis patients treated with mavrilimumab had significantly reduced disease activity and greater ARC20 response compared to placebo in phase IIB study.

There is no definitive evidence to suggest that obesity is associated with an increased risk of rheumatoid arthritis, but there is evidence that links obesity to more active disease and lack of treatment response. In this slideshow, we review the evidence.

Two doses of sirukumab, compared with placebo, improves the signs and symptoms of patients with active rheumatoid arthritis, researchers report.

MRI measures appear to be on target with patient-reported outcomes in rheumatoid arthritis, researchers report in ARD.

Schizophrenia and rheumatoid arthritis appear to have a DNA level connection.

Patients who didn't respond to methotrexate may do well on baricitinib.

Researchers evaluated children with arthritis, uveitis, and both.

Patient-reported outcomes are in line with clinical trial results for baricitinib, an international research team reports.

The 23-valent pneumococcal polysaccharide vaccine (PPSV23) does not prevent pneumonia in rheumatoid arthritis patients, a new study finds.

Advanced techniques allowed researchers to isolate T-cells involved in RA.

Biologics dose individualization should be used more often in clinical practice due to its direct benefit for patients with rheumatoid arthritis, researchers recommend.

Approximately one percent of the general population carries the auto-antibodies associated with rheumatoid arthritis, a new study shows.

A higher initial dose of methotrexate is not always associated with better clinical outcomes for newly diagnosed rheumatoid arthritis patients, a study shows.

Anti-inflammatory treatment in rheumatoid arthritis patients, especially with infliximab added to methotrexate, improves HDL function and may potentially reduce cardiovascular risk, a study shows.

RA patients with low disease activity in the first trimester of pregnancy, are likely to have low disease activity or reach remission by the third trimester.

The association between periodontal disease and rheumatoid arthritis has been well established in studies, but now researchers describe a mechanism that could explain this association.

Analysis finds that those with RA have same mortality rate as those without.

Myocardial inflammation/fibrosis has been identified in a study of rheumatoid arthritis patients with no known history of heart disease.

Some biologics produce hypersensitivity reactions more than others, but for most, the events are low, researchers report.

Methotrexate is "dramatically" underutilized, prescribed at suboptimal levels, prescribed for too short of periods and is not administered correctly, researchers report.

A rheumatoid arthritis patient seeks treatment for ankyloses, or fusion of the finger joints. The patient was successfully treated with silicone arthroplasty.

Women who have rheumatoid arthritis might benefit from treatment with denosumab over alendronate. According to a new study, denosumab is more effective at bone healing.

Asked to assume equal cost-effectiveness, the patients were given eight facets of treatment and asked to rank them between 1 and 8, with 1 being the most important to them and 8 being the least.